CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
June 2023—Randox Labs has released two new products, a prostate-specific antigen and brain natriuretic peptide control. The liquid-frozen PSA is manufactured using human serum and has an open-vial stability of 30 days at 2°–8°C and a shelf life of one year from the date of manufacture. The control is optimized for use with Roche systems but is also suitable for use across a variety of other platforms, the company says.
The BNP1-32 control is designed for use with in vitro diagnostics assays for the quantitative determination of BNP in human serum and plasma and optimized for use on Beckman Coulter, Abbott, and Siemens systems and suitable for other platforms as well. It has a 30-day open-vial stability at 2°–8°C.
Pages: 1 2